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Abstract
Introduction: Lassa fever is an acute arena viral haemorrhagic fever with varied neurological
sequelae. Sensorineural hearing loss is one of the rare complications which occur usually during the
convalescent stage of the infection.
Case presentation: The cases of two female patients aged 19 and 43 years old, respectively, with
clinical features suggestive of Lassa fever and confirmed by immunoserological/Lassa-virus-specific
reverse transcriptase polymerase chain reaction are presented. Both patients developed severe
sensorineural hearing loss at acute phases of the infections.
Conclusion: Sensorineural hearing loss from Lassa fever infections can occur in both acute and
convalescent stages and is probably induced by an immune response.
Introduction
Lassa fever is an acute arena viral haemorrhagic fever
which was first identified in Lassa village, Borno State in
the northeastern region of Nigeria in 1969 [1]. This
rodent-borne virus is highly contagious through the urine
of Mastomys natalensis (the multimammate rat) or via the
body fluid of infected humans. The clinical diagnosis is
often difficult because of the varied and non-specific
modes of presentation of Lassa fever.
Neurological complications, notably sensorineural hear-
ing loss, have been associated with Lassa fever. According
to a fairly recent WHO report, deafness occurs in about
25% of Lassa fever patients [2]. However, no case of sen-
sorineural hearing loss from patients confirmed with
Lassa fever has been reported in our environment, accord-
ing to a search we conducted on PubMed. Here, we
present the occurence of sensorineural hearing loss in two
confirmed cases of Lassa fever in Irrua, Nigeria.
Case presentation
Case report 1
A 19-year-old female undergraduate student presented to
our hospital on 5 December, 2003, with complaints of
high-grade fever of 9 days' duration; vomiting and
abdominal pain of 5 days' duration; headache of 4 days'
duration; as well as watery, non-mucous, non-bloody
diarrhoea and a sore throat, with difficulty in swallowing,
of 2 days' duration.
On examination, the patient was acutely ill looking, con-
scious and alert. Her temperature was 39.4°C; radial pulse
was 110 bpm, with regular, normal volume; blood pres-
sure was 100/60 mmHg in the supine position; and the
respiratory rate was 22 cycles/minute. A throat examina-
tion showed exudative pharyngitis. Petechial haemor-
rhages, prolonged bleeding from venepuncture sites and
nostrils, and bilateral hearing impairment were also
noticed. Apart from mild epigastric tenderness, examina-
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tion of the abdomen, chest- and central nervous systems
was unremarkable.
Investigations showed packed cell volume of 33%; eryth-
rocyte sedimentation rate (ESR) of 40 mm/hr (Wester-
green); total white blood cell (WBC) count of 2,400 mm;
neutrophil count of 30%, lymphocyte count of 70%; pro-
teinuria(++); a throat-swab culture grew alpha haemolytic
streptococci; and no malaria parasites were seen on a
blood-smear examination.
A clinical diagnosis of probable Lassa fever was made,
considering the endemic nature of the disease in our envi-
ronment. Blood samples were sent for definitive diagno-
sis. The results were positive for both Lassa virus-specific
IgM and Lassa virus-specific reverse transcriptase polymer-
ase chain reaction (RT-PCR), confirming the clinical diag-
nosis. The patient was admitted and treated with a 10-day
course of ribavirin, in addition to other supportive meas-
ures. She recovered, but had progressively worsening hear-
ing impairment. She was discharged 11 days after the
admission by the physicians and referred to the Ear, Nose
and Throat surgeons for management of the worsening
hearing disability. A review of our patient showed that the
pinnae and external auditory canal appeared normal,
while the tympanic membrane was intact and bilaterally
shiny. Tuning-fork tests (Rinne and Weber) were equivo-
cal.
A diagnosis of severe sensorineural hearing loss (SNHL)
was confirmed with a pure-tone audiogram, revealing a
hearing level in the left ear of 70 dB, in the right ear of 75
dB. Four years later, the patient's hearing was still signifi-
cantly impaired, and currently she uses a hearing-aid.
Case report 2
A 48-year-old female trader presented to our hospital on
20 August, 2007, with a 2-week history of fever and a 6-
day history of bilateral hearing loss. There was no history
of use of ototoxic drugs.
Physical examination revealed an ill-looking, conscious
and alert woman. The temperature at presentation was
36.9°C; pulse was 110 bpm, regular small volume; blood
pressure was 90/50 mmHg (supine position); and respira-
tory rate was 20 cycles/minute. There was bilateral conjuc-
tival haemorrhage. The pinnae appeared normal, whereas
the external auditory meatus contained scanty dry wax
which was evacuated manually. The tympanic mem-
branes were also intact and shiny. She was audiologically
confirmed to have bilateral severe SNHL (68 and 70 dB
hearing levels for left and right ear, respectively), culmi-
nating in her communicating through sign language.
There was no sign of meningeal irritation. The chest and
abdominal examinations were normal.
A clinical diagnosis of probable Lassa fever was made.
Laboratory investigations showed a packed cell volume of
34%, total WBC count of 7,300/mm3, neutrophil of 82%,
lymphocytes of 13% and platelets of 195 000. Urinalysis
showed protein (++). Lassa fever virus-specific RT-PCR
was positive for Lassa fever, thus confirming the clinical
diagnosis (although retrospectively). The patient
responded positively to a 10-day course of ribavirin. She
was discharged on 4 September, and one year afterwards,
severe SNHL still persisted.
Discussion
Viral infections such as mumps, rubeolla, rubella, herpes
zoster and cytomegalo viruses are known causes of hear-
ing loss in human. These infections usually lead to the
loss of hair and supporting cells of the cochlear during the
active phase of the infection. The tectorial membranes are
disrupted and the stria vascularis atrophy leading to end-
vessel thrombosis and inner-ear fibrosis. Direct invasion
of the spiral ganglion may also result in the loss of integ-
rity of the vestibulocochlear nerve [3]. All these patho-
genic processes are known to occur during the acute phase
of the viral infections. Often they result in sudden SNHL
and, because of limited diagnosis, most are classified as
idiopathic. About 57% to 60% of patients are known to
recover spontaneously during convalescence [4,5].
In contrast, hearing loss associated with Lassa fever infec-
tions usually occurs at the convalescent stage of the infec-
tions [6,7]. However, hearing loss following the illness
can also occur during the active phase of the illness as
illustrated in the above case series. Further deterioration
in hearing over time may be recorded even after full recov-
ery, as shown in Case 1. Cummins et al. [7] postulated
that the viraemia is not responsible for the hearing loss in
Lassa fever infections; instead, such hearing loss is due to
immune response reactions against the elements of the
inner ear. Similar observations were also made by Liao et
al. [8]. This notion is further supported by the fact that
early commencement of ribavirin therapy seems not to
offer protection against development of SNHL. Recent
research has shown that the strain of Lassa viruses found
at the West African coast varies in its amino-acid sequence
(genome) and tends to elaborate an already exaggerated
immune responses, involving high titers of IgG and IgM
[9,10]. Consequently, inhabitants of endemic areas of
Lassa fever with sub-clinical infections from exposures in
the past stand a higher risk of developing SNHL during
their lifetime.
One would have expected such an immunologically-
induced systemic hearing loss to be bilateral as demon-
strated clinically and by audiological assessment in the
above case reports. However, reports of unilateral sudden
SNHL associated with Lassa fever infection have been doc-Publish with BioMed Central    and   every 
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umented [11]. This raises further questions on the actual
mechanism involved in Lassa fever-induced SNHL. Fur-
ther research into this mechanism is necessary.
There is no active mode of management for Lassa fever-
induced hearing loss. Conservative methods include
hyperbaric labyrinthine vasodilators (e.g. nicotinic acid),
hyperbaric oxygen and carbogen therapy [12] to enhance
the oxygen pressure/perfusion to the inner ear. Steroids
and low molecular weight dextran have also been used.
However, there is no clear evidence on the efficacy of these
methods of treatment. The effect appears to be similar to
that seen in the management of idiopathic hearing loss
where most improved cases are believed to be spontane-
ous rather than as a result of treatment [5,13]. Hence, pre-
vention of contact with the Lassa fever virus and its main
vector remains the most efficient mode of control. In the
endemic areas such as Edo State, Nigeria, where multi-
mammate rats abound [14], total elimination of the vec-
tor of the virus is extremely difficult.
Innovative strides towards development of vaccines for
Lassa fever infections are currently being made. It was
recently reported that trials on primates have been suc-
cessful [15]. It will be important to determine the possible
long-term effects of the vaccines (immunological antibod-
ies) on the inner ear before application to human. This
poses further need for research on the mechanism of Lassa
virus-induced hearing loss.
Conclusion
SNHL from Lassa fever infection can occur at both active
and convalescent stages and is probably immune induced.
However, the definitive pathogenesis is key to advance-
ment into prophylactic and active treatment of the condi-
tion. Therefore, further research is urgently needed in this
field.
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